Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/2013

01-05-2013 | Correspondence

Dyslipidemia and Non-Alcoholic Fatty Liver Disease

Authors: Palaniappan Manickam, Rajeev Sudhakar

Published in: Digestive Diseases and Sciences | Issue 5/2013

Login to get access

Excerpt

We read with great interest the recent article by Otgonsuren et al. [1] on the independent predictors of mortality in patients with non-alcoholic fatty liver disease (NAFLD). The authors have comprehensively evaluated anthropometric and clinical factors associated with mortality in NAFLD. We would like to add some comments. …
Literature
1.
Otgonsuren M, Stepanova M, Gerber L, Younossi ZM. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-012-2446-3.
2.
Wit FW, Weverling GJ, Weel J, Jurriaans S, Lange JM. Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis. 2002;186:23–31.PubMedCrossRef
3.
Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74–80.PubMedCrossRef
4.
Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 2011;46:63–69.PubMedCrossRef
5.
Manickam P, Rathod A, Panaich S, et al. Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage? J Clin Lipidol. 2011;5:82–90.PubMedCrossRef
6.
Manickam P, Krishnamoorthi R. Impact of gender differences on incidence of diabetes in Hepatitis-C patients. Am J Gastroenterol. 2012;107:S198.
7.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterology (Multiple publications). Gastroenterology. 2012;142(7):1592–1609. doi:10.​1053/​j.​gastro.​2012.​04.​001 (Am J Gastroenterol. 2012;107(6):811–826. doi:10.​1038/​ajg.​2012.​128; Hepatology. 2012;55(6):2005–2023. doi:10.​1002/​hep.​25762).
8.
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750.PubMedCrossRef
9.
Metadata
Title
Dyslipidemia and Non-Alcoholic Fatty Liver Disease
Authors
Palaniappan Manickam
Rajeev Sudhakar
Publication date
01-05-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2577-1

Other articles of this Issue 5/2013

Digestive Diseases and Sciences 5/2013 Go to the issue

Correspondence

Endoscopic Large Balloon Dilation After Sphincterotomy: Is Perforation Risk an Alarming Issue?

Original Article

Functional Roles of TGF-β1 in Intestinal Epithelial Cells Through Smad-Dependent and Non-Smad Pathways

Original Article

Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4−/− Mouse Model

Stanford Multidisciplinary Seminars

A Moving Cause of Gastrointestinal Bleeding

Original Article

Assessing Health Status in Inflammatory Bowel Disease Using a Novel Single-Item Numeric Rating Scale

Original Article

Safety and Effectiveness of Low-Dose Propofol Sedation During and After Esophagogastroduodenoscopy in Child A and B Cirrhotic Patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits